Next Article in Journal
Phylogeography and Genetic Differentiation among Populations of the Moon Turban Snail Lunella granulata Gmelin, 1791 (Gastropoda: Turbinidae)
Previous Article in Journal
Role of Melatonin in Schizophrenia
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2013, 14(5), 9051-9061; https://doi.org/10.3390/ijms14059051

IGF-1 Antibody Prolongs the Effective Duration Time of Botulinum Toxin in Decreasing Muscle Strength

1
Department of Neurology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China
2
Department of Biomedicine, China National Center for Biotechnology Development, Beijing 100036, China
These authors contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Received: 18 February 2013 / Revised: 28 March 2013 / Accepted: 15 April 2013 / Published: 25 April 2013
(This article belongs to the Section Biochemistry)
Full-Text   |   PDF [612 KB, uploaded 19 June 2014]

Abstract

Botulinum toxin type-A (Btx-A), a powerful therapeutic tool in various medical specialties, requires repeated injections to maintain its effect. Therefore, novel methods to prolong the effective duration time of Btx-A are highly needed. Rats were assigned to three major groups: control group (n = 30), Btx-A group (n = 30), and IGF-1 Ab groups. IGF-1 Ab groups were composed by sub-groups A1–A5 (each has 25 rats) for the subsequent IGF-1Ab dose-effect study. Muscle strength was determined by a survey system for rat lower limbs nerve and muscle function. Muscle-specific receptor tyrosine kinase (MuSK), Insulin-like growth factor binding protein-5 (IGFBP5), and growth-associated protein, 43-kDa (GAP43) were determined by real-time polymerase chain reactions (PCRs) and Western blot. We found that Btx-A decreased the muscle strength, with a paralysis maintained for 70 days. IGF-1Ab prolonged the effective duration time of Btx-A. Real-time PCRs and Western blot showed that IGF-1Ab delayed the increase of MuSK and IGFBP5 after Btx-A injection, without affecting GAP43. These results indicate that IGF-1Ab might prolong the effective duration time of Btx-A on muscle strength through delaying the increase of MuSK. It would be interesting to determine whether IGF-1Ab can be used as an auxiliary measure to the Btx-A treatment in the future. View Full-Text
Keywords: botulinum toxin; insulin-like growth factor 1; muscle strength; muscle-specific receptor tyrosine kinase botulinum toxin; insulin-like growth factor 1; muscle strength; muscle-specific receptor tyrosine kinase
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Jin, L.; Pan, L.; Liu, W.; Guo, Y.; Zheng, Y.; Guan, Q.; Nie, Z. IGF-1 Antibody Prolongs the Effective Duration Time of Botulinum Toxin in Decreasing Muscle Strength. Int. J. Mol. Sci. 2013, 14, 9051-9061.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top